0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
JAMA Patient Page |

Lung Cancer Screening FREE

Phillip M. Boiselle, MD; Cassio Lynm, MA; Edward H. Livingston, MD
JAMA. 2013;309(18):1948. doi:10.1001/jama.2013.4324.
Text Size: A A A
Published online

Lung cancer is the international leading cause of cancer deaths. Tobacco use is the principal risk factor for lung cancer and accounts for at least 85% of all lung cancers. Until recently, no screening test had been shown to be effective in reducing deaths associated with this disease.

SCREENING TESTS FOR LUNG CANCER

Screening tests detect cancer before symptoms develop, with the goal of decreasing the risk of dying of cancer. Detecting cancers earlier may provide a better chance of a cure. Low-dose computed tomography (CT) scans of the chest are used for lung cancer screening. Low-dose means that lower radiation doses are used compared with a regular diagnostic CT scan.

DOES SCREENING FOR LUNG CANCER WORK?

  • A large study of patients at high risk of lung cancer (the National Lung Screening Trial [NLST]) showed that CT screening reduced lung cancer deaths by 20% (1.33% in those screened compared with 1.67% in those not screened).

  • People at high risk of lung cancer are aged 55 years to 74 years, have at least a 30-pack-year smoking history, and are currently smokers or have quit within the past 15 years.

  • In the NLST, CT screening had a high false-positive rate and used ionizing radiation. A false-positive result means that a positive screening result is later found to not represent lung cancer. In the NLST, false-positive results occurred in about 1 of every 4 baseline and first-year annual CT screening examinations.

  • The NLST found that 320 people at high risk of lung cancer needed to be screened to prevent 1 death from lung cancer.

  • False-positive results may cause unnecessary testing and follow-up. Most false-positive test results are resolved by performing a regular CT scan. Others lead to more invasive testing, such as biopsies or surgical intervention.

  • Potential harms of CT screening include radiation exposure and the need for additional tests, some of which require invasive procedures and can create anxiety.

  • The most effective frequency and duration of lung cancer screening is unknown.

WHERE TO START

If you believe that you meet the criteria for a high risk of lung cancer, make an appointment to visit your primary care physician. She or he can conduct an evaluation and assist in helping you decide whether lung cancer screening with low-dose CT is appropriate for you.

FOR MORE INFORMATION

INFORM YOURSELF

To find this and previous JAMA Patient Pages, go to the Patient Page Index on JAMA 's website at www.jama.com. Many are available in English and Spanish.

The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.

Sources: National Cancer Institute, American Cancer Society

Topic: LUNG CANCER

ARTICLE INFORMATION

Conflict of Interest Disclosures: The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Spanish Patient Page: Detección del cáncer de pulmón

Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles